vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and American Express (AXP). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $18.9M, roughly 53.6× American Express). American Express runs the higher net margin — 15.7% vs -1.1%, a 16.8% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 11.4%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs -95.6%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...

ALHC vs AXP — Head-to-Head

Bigger by revenue
ALHC
ALHC
53.6× larger
ALHC
$1.0B
$18.9M
AXP
Growing faster (revenue YoY)
ALHC
ALHC
+33.0% gap
ALHC
44.4%
11.4%
AXP
Higher net margin
AXP
AXP
16.8% more per $
AXP
15.7%
-1.1%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
-95.6%
AXP

Income Statement — Q4 2025 vs Q1 2026

Metric
ALHC
ALHC
AXP
AXP
Revenue
$1.0B
$18.9M
Net Profit
$-11.0M
$3.0M
Gross Margin
Operating Margin
-1.0%
Net Margin
-1.1%
15.7%
Revenue YoY
44.4%
11.4%
Net Profit YoY
64.6%
15.0%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
AXP
AXP
Q1 26
$18.9M
Q4 25
$1.0B
$10.9B
Q3 25
$993.7M
$10.4B
Q2 25
$1.0B
$10.3B
Q1 25
$926.9M
$9.6B
Q4 24
$701.2M
$10.0B
Q3 24
$692.4M
$9.7B
Q2 24
$681.3M
$9.8B
Net Profit
ALHC
ALHC
AXP
AXP
Q1 26
$3.0M
Q4 25
$-11.0M
$2.5B
Q3 25
$3.7M
$2.9B
Q2 25
$15.7M
$2.9B
Q1 25
$-9.1M
$2.6B
Q4 24
$-31.1M
$2.2B
Q3 24
$-26.4M
$2.5B
Q2 24
$-24.0M
$3.0B
Operating Margin
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
-1.0%
28.2%
Q3 25
0.8%
36.7%
Q2 25
2.2%
34.4%
Q1 25
-0.6%
34.6%
Q4 24
-3.2%
27.7%
Q3 24
-2.8%
33.0%
Q2 24
-2.7%
38.6%
Net Margin
ALHC
ALHC
AXP
AXP
Q1 26
15.7%
Q4 25
-1.1%
22.5%
Q3 25
0.4%
27.9%
Q2 25
1.5%
28.0%
Q1 25
-1.0%
26.8%
Q4 24
-4.4%
21.8%
Q3 24
-3.8%
25.8%
Q2 24
-3.5%
30.7%
EPS (diluted)
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
$-0.04
$3.52
Q3 25
$0.02
$4.14
Q2 25
$0.07
$4.08
Q1 25
$-0.05
$3.64
Q4 24
$-0.15
$3.04
Q3 24
$-0.14
$3.49
Q2 24
$-0.13
$4.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
AXP
AXP
Cash + ST InvestmentsLiquidity on hand
$604.2M
Total DebtLower is stronger
$323.2M
$60.4M
Stockholders' EquityBook value
$179.3M
$34.0M
Total Assets
$1.1B
$308.9M
Debt / EquityLower = less leverage
1.80×
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
$604.2M
$742.0M
Q3 25
$644.1M
$1.3B
Q2 25
$503.8M
$197.0M
Q1 25
$479.5M
$261.0M
Q4 24
$470.6M
$221.0M
Q3 24
$381.0M
$120.0M
Q2 24
$363.7M
$188.0M
Total Debt
ALHC
ALHC
AXP
AXP
Q1 26
$60.4M
Q4 25
$323.2M
$56.4B
Q3 25
$322.7M
$57.8B
Q2 25
$322.3M
$58.2B
Q1 25
$321.9M
$51.2B
Q4 24
$321.4M
$49.7B
Q3 24
$212.0M
$53.5B
Q2 24
$211.7M
$51.5B
Stockholders' Equity
ALHC
ALHC
AXP
AXP
Q1 26
$34.0M
Q4 25
$179.3M
$33.5B
Q3 25
$161.9M
$32.4B
Q2 25
$141.0M
$32.3B
Q1 25
$108.1M
$31.2B
Q4 24
$99.9M
$30.3B
Q3 24
$114.5M
$29.7B
Q2 24
$123.7M
$29.5B
Total Assets
ALHC
ALHC
AXP
AXP
Q1 26
$308.9M
Q4 25
$1.1B
$300.1B
Q3 25
$1.1B
$297.6B
Q2 25
$1.0B
$295.6B
Q1 25
$895.6M
$282.2B
Q4 24
$782.1M
$271.5B
Q3 24
$692.3M
$271.0B
Q2 24
$716.3M
$272.2B
Debt / Equity
ALHC
ALHC
AXP
AXP
Q1 26
1.78×
Q4 25
1.80×
1.68×
Q3 25
1.99×
1.78×
Q2 25
2.29×
1.80×
Q1 25
2.98×
1.64×
Q4 24
3.22×
1.64×
Q3 24
1.85×
1.80×
Q2 24
1.71×
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
AXP
AXP
Operating Cash FlowLast quarter
$-50.4M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
$-50.4M
$3.1B
Q3 25
$144.6M
$6.2B
Q2 25
$29.1M
$4.4B
Q1 25
$16.6M
$4.8B
Q4 24
$-8.7M
$5.8B
Q3 24
$26.2M
$-1.8B
Q2 24
$23.5M
$4.5B
Free Cash Flow
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
$-55.4M
$2.3B
Q3 25
$139.1M
$5.6B
Q2 25
$21.1M
$3.7B
Q1 25
$8.4M
$4.3B
Q4 24
$-18.0M
$5.3B
Q3 24
$16.9M
$-2.3B
Q2 24
$11.8M
$4.0B
FCF Margin
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
-5.5%
21.4%
Q3 25
14.0%
53.6%
Q2 25
2.1%
36.3%
Q1 25
0.9%
45.0%
Q4 24
-2.6%
53.1%
Q3 24
2.4%
-23.3%
Q2 24
1.7%
40.4%
Capex Intensity
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
0.5%
6.6%
Q3 25
0.6%
6.3%
Q2 25
0.8%
6.0%
Q1 25
0.9%
4.5%
Q4 24
1.3%
5.0%
Q3 24
1.3%
4.7%
Q2 24
1.7%
5.8%
Cash Conversion
ALHC
ALHC
AXP
AXP
Q1 26
Q4 25
1.25×
Q3 25
38.77×
2.15×
Q2 25
1.86×
1.51×
Q1 25
1.84×
Q4 24
2.66×
Q3 24
-0.72×
Q2 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

AXP
AXP

Discount revenue$9.5M50%
Other$8.9M47%
Deposits with banks and other$512.0K3%

Related Comparisons